Manufacturing

Manufacturing

R-Pharm’s production designed with account to all latest GMP requirements, which is unprecedented for Russia, especially for the production of aseptic injection drug formulations.

Новости

При поддержке "Р-Фарм" состоится IV Всероссийская студенческая фармацевтическая Олимпиада

При поддержке "Р-Фарм" состоится IV Всероссийская студенческая фармацевтическая Олимпиада

27-30 января в Санкт-Петербурге состоится IV Всероссийская студенческая фармацевтическая Олимпиада (ВСФО)

Jan. 22, 2015

R-Pharm Group of Companies Participated in JP Morgan Healthcare Conference 2015

R-Pharm Group of Companies Participated in JP Morgan Healthcare Conference 2015

On January 12, in San Francisco, CA, USA, there started functioning 33d annual J.P. Morgan Healthcare Conference that joined together world leaders of pharmaceutical industry and innovative biotechnological companies.

Jan. 12, 2015

R-Pharm and Il-Yang Pharmaceutical Reach Agreement on Consumer Promotion of Supect (Radotinib) Medicine in RF

news

R-Pharm corporate group and Il-Yang Pharmaceutical Co., Ltd., a Korean company, with assistance of Taishi corporate group have reached a frame agreement related to their activity in Russia.

Dec. 17, 2014

R-Pharm develops medicine to treat alcohol addiction

news

In November 2014 there took place a meeting of researchers in the framework of multi-center randomized double blind placebo controlled phase III clinical studies for assessment of efficacy and safety of Odelepran, a tablet-form medicine, applied by patients suffering from alcohol addiction. Currently enrollment of patients for the research is taking place in nineteen leading detoxification centers of the Russian Federation.

Dec. 16, 2014

RVC and R-Pharm Establish New Venture Fund

RVC and R-Pharm Establish New Venture Fund

RVC together with R-Pharm company have announced establishment of venture fund in the sphere of medical technologies. The fund is called RusBio Ventures. Amount of finance operated by the fund at first closing will equal two billion seventy million rubles. New fund will become the first large investment partnership created in Russian Federation with the participation of RVC and the private investor.

Dec. 4, 2014
News Archive →